Biotricity, Inc. Common Stock
BTCY
BTCY was delisted on the 2nd of August, 2024.
29 hedge funds and large institutions have $11.2M invested in Biotricity, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.
5,748% more capital inflows, than outflows
Capital inflows: $10.6M | Capital outflows: $181K
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
350% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 4
216% more call options, than puts
Call options by funds: $426K | Put options by funds: $135K
93% more funds holding
Funds holding: 15 → 29 (+14)
5.52% more ownership
Funds ownership: 0.42% → 5.94% (+5.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.53M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.37M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$1.13M |
| 4 |
Kingsview Wealth Management
Grants Pass,
Oregon
|
+$428K |
| 5 |
BlackRock
New York
|
+$315K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MFG
Magnus Financial Group
New York
|
-$54K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$48.9K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$38K |
| 4 |
SG
StoneX Group
New York
|
-$32K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$8.04K |
BTCY Hedge Fund Activity: Q4 2021 in Review
29 of the 6,521 institutional investors tracked by Wall St. Rank reported a position in Biotricity, Inc. Common Stock (BTCY) for Q4 2021, worth a combined $11.2M — up 1,891% from $564K a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new BTCY positions and 4 closed out — a net gain of 14 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $6.53M. The largest seller was Magnus Financial Group, exiting entirely with an estimated $54K sold.
- 29 institutional investors held Biotricity, Inc. Common Stock (BTCY) as of Q4 2021, up from 15 in Q3 2021.
- Funds reported $11.2M of Biotricity, Inc. Common Stock stock for Q4 2021, up 1,891% quarter-over-quarter.
- 18 funds opened new Biotricity, Inc. Common Stock positions in Q4 2021 and 4 closed out, a net change of +14 holders.
- The largest Biotricity, Inc. Common Stock buyer in Q4 2021 was Vanguard Group, an estimated $6.53M added.
- The largest Biotricity, Inc. Common Stock seller in Q4 2021 was Magnus Financial Group, an estimated $54K sold.
Based on aggregated 13F filings for Q4 2021.